Renal amyloidosis in children

被引:67
作者
Bilginer, Yelda [1 ]
Akpolat, Tekin [2 ]
Ozen, Seza [1 ]
机构
[1] Hacettepe Univ, Fac Med, Pediat Nephrol & Rheumatol Unit, TR-06100 Ankara, Turkey
[2] Ondokuz Mayis Univ, Sch Med, Dept Nephrol, Samsun, Turkey
关键词
Renal amyloidosis; Children; Autoinflammatory diseases; FAMILIAL MEDITERRANEAN FEVER; COLD AUTOINFLAMMATORY SYNDROME; JUVENILE CHRONIC ARTHRITIS; CLINICAL-FEATURES; SYSTEMIC AMYLOIDOSIS; PERIODIC SYNDROME; SECONDARY AMYLOIDOSIS; COLCHICINE TOXICITY; AA AMYLOIDOSIS; AL AMYLOIDOSIS;
D O I
10.1007/s00467-011-1797-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Renal amyloidosis is a detrimental disease caused by the deposition of amyloid fibrils. A child with renal amyloidosis may present with proteinuria or nephrotic syndrome. Chronic renal failure may follow. Amyloid fibrils may deposit in other organs as well. The diagnosis is through the typical appearance on histopathology. Although chronic infections and chronic inflammatory diseases used to be the causes of secondary amyloidosis in children, the most frequent cause is now autoinflammatory diseases. Among this group of diseases, the most frequent one throughout the world is familial Mediterranean fever (FMF). FMF is typically characterized by attacks of clinical inflammation in the form of fever and serositis and high acute-phase reactants. Persisting inflammation in inadequately treated disease is associated with the development of secondary amyloidosis. The main treatment is colchicine. A number of other monogenic autoinflammatory diseases have also been identified. Among them cryopyrin-associated periodic syndrome (CAPS) is outstanding with its clinical features and the predilection to develop secondary amyloidosis in untreated cases. The treatment of secondary amyloidosis mainly depends on the treatment of the disease. However, a number of new treatments for amyloid per se are in the pipeline.
引用
收藏
页码:1215 / 1227
页数:13
相关论文
共 109 条
[1]   Renal Behcet's disease: A cumulative analysis [J].
Akpolat, T ;
Akkoyunlu, M ;
Akpolat, I ;
Dilek, M ;
Odabas, AR ;
Ozen, S .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2002, 31 (05) :317-337
[2]   The tumor-necrosis-factor receptor-associated periodic syndrome:: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers [J].
Aksentijevich, I ;
Galon, J ;
Soares, M ;
Mansfield, E ;
Hull, K ;
Oh, HH ;
Goldbach-Mansky, R ;
Dean, J ;
Athreya, B ;
Reginato, AJ ;
Henrickson, M ;
Pons-Estel, B ;
O'Shea, JJ ;
Kastner, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :301-314
[3]  
Aksentijevich I, 1997, CELL, V90, P797
[4]   Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure:: A single-centre experience from Turkey [J].
Altiparmak, MR ;
Pamuk, ÖN ;
Ataman, R ;
Serdengeçti, K .
NEPHRON CLINICAL PRACTICE, 2004, 98 (04) :C119-C123
[5]   Safety of colchicine in dialysis patients [J].
Anderson-Hoog, T ;
Patel, B .
SEMINARS IN DIALYSIS, 2003, 16 (05) :412-413
[6]   DIALYSIS IN RENAL-FAILURE CAUSED BY AMYLOIDOSIS OF FAMILIAL MEDITERRANEAN FEVER - REPORT OF 10 CASES [J].
ARI, JB ;
ZLOTNIK, M ;
OREN, A ;
BERLYNE, GM .
ARCHIVES OF INTERNAL MEDICINE, 1976, 136 (04) :449-451
[7]   COLCHICINE-INDUCED MODULATION OF COLLAGENASE IN HUMAN-SKIN FIBROBLAST-CULTURES .1. STIMULATION OF ENZYME-SYNTHESIS IN NORMAL-CELLS [J].
BAUER, EA ;
VALLE, KJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 (06) :398-402
[8]  
Ben-Chetrit E, 2003, J NEPHROL, V16, P431
[9]   Familial Mediterranean fever [J].
Ben-Chetrit, E ;
Levy, M .
LANCET, 1998, 351 (9103) :659-664
[10]   The hereditary amyloidoses [J].
Benson, MD .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (06) :909-927